KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 110 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 1.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $0 | – | 0 | – | 0.00% | – |
Q1 2021 | $0 | – | 0 | – | 0.00% | – |
Q4 2020 | $0 | – | 0 | – | 0.00% | – |
Q3 2020 | $0 | – | 0 | – | 0.00% | – |
Q2 2020 | $0 | – | 0 | – | 0.00% | – |
Q1 2020 | $0 | – | 0 | – | 0.00% | – |
Q4 2019 | $0 | – | 0 | – | 0.00% | – |
Q3 2019 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
Q4 2018 | $52,000 | +62.5% | 5,650 | +197.4% | 0.00% | +200.0% |
Q3 2018 | $32,000 | +3.2% | 1,900 | +5.6% | 0.00% | 0.0% |
Q2 2018 | $31,000 | +3000.0% | 1,800 | +1100.0% | 0.00% | – |
Q1 2018 | $1,000 | 0.0% | 150 | 0.0% | 0.00% | – |
Q4 2017 | $1,000 | -50.0% | 150 | 0.0% | 0.00% | – |
Q3 2017 | $2,000 | +100.0% | 150 | 0.0% | 0.00% | – |
Q2 2017 | $1,000 | -50.0% | 150 | 0.0% | 0.00% | – |
Q1 2017 | $2,000 | +100.0% | 150 | 0.0% | 0.00% | – |
Q4 2016 | $1,000 | 0.0% | 150 | 0.0% | 0.00% | – |
Q3 2016 | $1,000 | -75.0% | 150 | -76.9% | 0.00% | – |
Q2 2016 | $4,000 | -42.9% | 650 | +30.0% | 0.00% | – |
Q4 2015 | $7,000 | – | 500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AIGH Capital Management LLC | 1,773,474 | $2,376,456 | 1.12% |
AlphaCentric Advisors LLC | 1,125,000 | $1,507,500 | 0.86% |
Tejara Capital Ltd | 1,077,388 | $1,443,700 | 0.82% |
Palo Alto Investors LP | 5,675,876 | $7,605,674 | 0.72% |
Birchview Capital, LP | 571,832 | $766,255 | 0.65% |
Altium Capital Management LP | 740,000 | $991,600 | 0.52% |
Avidity Partners Management LP | 8,298,570 | $11,120,084 | 0.45% |
Worth Venture Partners, LLC | 445,981 | $597,615 | 0.36% |
SILVERARC CAPITAL MANAGEMENT, LLC | 561,955 | $753,020 | 0.23% |
DAFNA Capital Management LLC | 192,678 | $258,189 | 0.08% |